Raymond James & Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-54,794	Closed	-$624K	–	4031
2021 Q3	$624K	Sell	54,794 -4,424	-7%	-$50.4K	﹤0.01%	2893
2021 Q2	$825K	Buy	59,218 +21,458	+57%	+$299K	﹤0.01%	2716
2021 Q1	$699K	Sell	37,760 -13,645	-27%	-$253K	﹤0.01%	2755
2020 Q4	$908K	Buy	+51,405	New	+$908K	﹤0.01%	2405